January 22, 2020
Allergan PLC and Ironwood Pharmaceuticals Inc. have agreed to give Teva Pharmaceuticals USA a license to sell generic versions of the irritable bowel syndrome medication Linzess in March 2029, winning the earliest launch date of the various companies sued for infringement.
December 01, 2016
Allergan USA Inc. hit four generic-drug makers with a suit Wednesday in Delaware federal court accusing them of jumping the gun on producing a generic version of its irritable bowel syndrome treatment Linzess.